Filing Details

Accession Number:
0001214659-21-002747
Form Type:
4
Zero Holdings:
No
Publication Time:
2021-03-04 17:25:37
Reporting Period:
2021-03-02
Accepted Time:
2021-03-04 17:25:37
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1576263 Mirati Therapeutics Inc. MRTX Pharmaceutical Preparations (2834) 462693615
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1781315 M Julie Cherrington C/O Mirati Therapeutics, Inc.
9393 Towne Centre Drive, Ste 200
San Diego CA 92121
No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2021-03-02 1,990 $201.00 1,485 No 4 S Direct
Common Stock Disposition 2021-03-02 10 $203.00 1,475 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
No 4 S Direct